Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Figure 7

Change from baseline in eGFR over the 24-week follow-up period in the CKD stage 3b subgroup.